Pathkey.AI Information

Pathkey.AI Limited (ASX: PKY) is an Australian Securities Exchange listed technology company focused on applied artificial intelligence and advanced computing. We build AI-native businesses in high-value industries that have been slow to modernise. Each company in the group targets a costly, expert-driven process and uses AI to make it faster, more predictable and easier to scale. Chipforge AI-native semiconductor design. Engineers describe design intent and Chipforge generates RTL with verification built in, using its Reflexion loop to converge quickly on working hardware. Chipforge covers FPGA through to ASIC, runs on its own models for cloud or air-gapped deployment, and is designed to work alongside existing EDA toolchains. Chipforge operates from Australia and Singapore and serves semiconductor and design-services teams across Asia Pacific. TrialKey AI for clinical-trial design. TrialKey predicts and simulates studies before they run, drawing on decades of curated trial data to support outcome prediction and generative protocol design. It gives sponsors, CROs and pharmaceutical teams a way to test design choices early and reduce costly amendments. Pathkey.AI provides the listed platform, capital and governance for these businesses to grow. Investor information and ASX announcements are available at pathkey.ai.